Skip to content

Member

Marie TOUSSAINT

Greens · France

Group
Greens Verts/ALE
Country
France
Roll-call participation
90.3 %ⓘ of 2 521 roll calls in office · chamber median 90.9 % · 2026, roll calls
With majority line
91.3 %ⓘ of 2 276 votes where the group had a line · Greens median 97.5 %
More facts (5)
National party
Les Écologistes
In office
Since 16 Jul 2024
Against clear line
176 of 2 237 votesⓘ
Committees
ECON, ENVI (substitute), ITRE (substitute), SANT (substitute)
Member id
97236
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

90.3 %

2 277 of 2 521 roll calls while in office

Greens median: 92.5 % (−2.1 pts)

Chamber median: 90.9 %

With majority line ⓘ

91.3 %

2 077 of 2 276 votes where their group had a line

Greens median: 97.5 % (−6.2 pts)

Against clear line ⓘ

7.9 %

176 of 2 237 votes where their group had a clear line

81 opposite (for ↔ against), 29 abstained against the line, 66 voted for or against when the line was to abstain

Abstention ⓘ

2.3 %

53 of 2 277 votes cast

Participation 90.3 % — Greens median 92.5 %, 54 members.ⓘ
Data as a table
Participation among the 54 members of the Greens with enough votes.
FigureParticipation
Marie TOUSSAINT90.3 %
Greens median92.5 %
Lowest in the group21.5 %
Highest in the group99.8 %
Members54
With majority line 91.3 % — Greens median 97.5 %, 54 members.ⓘ
Data as a table
With majority line among the 54 members of the Greens with enough votes.
FigureWith majority line
Marie TOUSSAINT91.3 %
Greens median97.5 %
Lowest in the group88.5 %
Highest in the group99.6 %
Members54
  • 2026, 2 521 roll-call votes. The dots are the other members of Greens; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecisionResultPositionMajority line
29 Apr 2026Discharge 2024: European Public Prosecutor’s Office Discharge decision adopted 454 for, 161 against, 29 abstainedPosition: For Majority line: For
29 Apr 2026Discharge 2024: Agencies Discharge decision adopted 475 for, 107 against, 71 abstainedPosition: For Majority line: For
29 Apr 2026Discharge 2024: Joint Undertakings Discharge decision adopted 525 for, 104 against, 16 abstainedPosition: For Majority line: For
29 Apr 2026Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/008 BE/Liberty - Belgium Passed 586 for, 48 against, 16 abstainedPosition: For Majority line: For
29 Apr 2026Genetically modified soybean MON 94637 Objection passed 412 for, 145 against, 11 abstainedPosition: For Majority line: For
29 Apr 2026Situation of fundamental rights in the European Union in 2024 and 2025 Adopted 328 for, 199 against, 98 abstainedPosition: For Majority line: For
29 Apr 2026The Commission’s 2025 Rule of Law report Adopted 387 for, 191 against, 46 abstainedPosition: For Majority line: For
29 Apr 2026Monitoring the application of European Union law in 2023, 2024 and 2025 Adopted 416 for, 190 against, 15 abstainedPosition: For Majority line: For
28 Apr 2026Generalised scheme of tariff preferences Passed 459 for, 127 against, 70 abstainedPosition: Against Majority line: For
28 Apr 2026Welfare of dogs and cats and their traceability Passed 558 for, 35 against, 52 abstainedPosition: For Majority line: For
28 Apr 2026Amendments to Biocidal Products Regulation as regards the extension of certain data protection periods Passed 591 for, 54 against, 8 abstainedPosition: For Majority line: For
28 Apr 2026European Globalisation Adjustment Fund: workers affected by imminent job displacement Passed 566 for, 67 against, 26 abstainedPosition: For Majority line: For
28 Apr 2026Interim report on the proposal for the multiannual financial framework for 2028-2034 Interim report adopted 370 for, 201 against, 84 abstainedPosition: For Majority line: For
28 Apr 2026Guidelines for the 2027 budget - Section III Adopted 389 for, 191 against, 75 abstainedPosition: For Majority line: For
28 Apr 2026Amendments to Parliament's Rules of Procedure concerning appointments to Union agencies and bodies (Rule 135) Adopted 657 for, 0 against, 3 abstainedPosition: For Majority line: For
28 Apr 2026Control of the financial activities of the European Investment Bank Group – annual report 2024 Adopted 377 for, 254 against, 31 abstainedPosition: Against Majority line: Against
28 Apr 2026Importance of consent-based rape legislation in the EU Adopted 447 for, 160 against, 43 abstainedPosition: For Majority line: For
28 Apr 2026Protection of the European Union’s financial interests – combating fraud – annual report 2024 Rejected 231 for, 389 against, 33 abstainedPosition: Against Majority line: Against
28 Apr 2026The role of ocean diplomacy for the competitiveness of EU fisheries and aquaculture Adopted 430 for, 107 against, 115 abstainedPosition: Abstained Majority line: Abstained
28 Apr 2026Control, transparency and traceability of performance-based instruments Adopted 527 for, 85 against, 33 abstainedPosition: No vote recorded Majority line: For
28 Apr 2026Enhancing connectivity, preserving cultural heritage and driving local excellence in European tourism – destination management and regional tourism growth Adopted 439 for, 42 against, 129 abstainedPosition: Abstained ≠ groupMajority line: For
28 Apr 2026Extension of the term of office of the Special Committee on the European Democracy Shield Adopted 422 for, 202 against, 9 abstainedPosition: For Majority line: For
26 Mar 2026Common system for the return of third-country nationals staying illegally in the Union (Return Regulation) Negotiating mandate approved 389 for, 206 against, 32 abstainedPosition: Against Majority line: Against
26 Mar 2026Combating corruption Passed 581 for, 21 against, 42 abstainedPosition: For Majority line: For
26 Mar 2026Proposal for a regulation of the European Parliament and of the Council amending Regulation (EU) 2021/1232 as regards the extension of its period of application Failed 228 for, 311 against, 92 abstainedPosition: Against Majority line: Against
26 Mar 2026Adjustment of customs duties and opening of tariff quotas for the import of certain goods originating in the United States of America Passed 417 for, 154 against, 71 abstainedPosition: Against Majority line: Against
26 Mar 2026Non-application of customs duties on imports of certain goods Passed 437 for, 144 against, 60 abstainedPosition: Against Majority line: Against
26 Mar 2026Simplification of the implementation of harmonised rules on artificial intelligence (Digital Omnibus on AI) Passed 569 for, 45 against, 23 abstainedPosition: Against ≠ groupMajority line: For
26 Mar 2026United Nations Convention on the International Effects of Judicial Sales of Ships Consent given 605 for, 3 against, 9 abstainedPosition: No vote recorded Majority line: For
26 Mar 2026EU-China Agreement: modification of concessions on all the tariff rate quotas included in the EU Schedule CLXXV Consent given 603 for, 3 against, 33 abstainedPosition: For Majority line: For
26 Mar 2026EU-Lebanon Agreement for scientific and technological cooperation setting, participation of Lebanon in the Partnership for Research and Innovation in the Mediterranean Area (PRIMA) Consent given 618 for, 6 against, 5 abstainedPosition: No vote recorded Majority line: For
26 Mar 2026Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/005 AT/KTM - Austria Passed 584 for, 39 against, 13 abstainedPosition: For Majority line: For
26 Mar 2026Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/007 BE/Casa - Belgium Passed 575 for, 48 against, 10 abstainedPosition: For Majority line: For
26 Mar 2026Union framework for the national calculation of life-cycle global warming potential Objection failed 208 for, 414 against, 10 abstainedPosition: Against Majority line: Against
26 Mar 2026Global Gateway – past impacts and future orientation Adopted 371 for, 146 against, 80 abstainedPosition: Against ≠ groupMajority line: For
12 Mar 2026Calculation of emission credits for heavy-duty vehicles for the reporting periods of the years 2025 to 2029 Passed 473 for, 81 against, 9 abstainedPosition: Against Majority line: Against
12 Mar 2026Package travel and linked travel arrangements: make the protection of travellers more effective and simplify and clarify certain aspects Passed 537 for, 2 against, 24 abstainedPosition: For Majority line: For
12 Mar 2026Human trafficking and grave human rights violations linked to the recruitment of non-Russian nationals, in particular from Africa, for Russia’s war of aggression in Ukraine Adopted 479 for, 17 against, 43 abstainedPosition: For Majority line: For
12 Mar 2026The arbitrary detention of President Mohamed Bazoum by the junta in Niger Adopted 524 for, 2 against, 29 abstainedPosition: For Majority line: For
12 Mar 2026Case of Elene Khoshtaria and political prisoners under the Georgian Dream regime Adopted 438 for, 37 against, 81 abstainedPosition: For Majority line: For
12 Mar 2026Activities of the European Ombudsman – annual report 2024 Rejected 233 for, 250 against, 76 abstainedPosition: Against Majority line: Against
11 Mar 2026Proposal for a regulation of the European Parliament and of the Council amending Regulation (EU) 2021/1232 as regards the extension of its period of application Passed 458 for, 103 against, 63 abstainedPosition: For Majority line: For
11 Mar 2026Council of Europe Framework Convention on Artificial Intelligence and Human Rights, Democracy and the Rule of Law Consent given 455 for, 101 against, 74 abstainedPosition: For Majority line: For
11 Mar 2026EU-Ecuador Agreement: cooperation between Europol and the Ecuadorian authorities competent for combating serious crime and terrorism Consent given 586 for, 21 against, 11 abstainedPosition: No vote recorded Majority line: For
11 Mar 2026Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/004 BE/Tupperware – Belgium Passed 562 for, 53 against, 19 abstainedPosition: For Majority line: For
11 Mar 2026Framework Agreement on relations between the European Parliament and the European Commission Adopted 446 for, 100 against, 72 abstainedPosition: For Majority line: For
11 Mar 2026Gender pay and pension gap in the EU: state of play, challenges and the way forward, and developing guidelines for the better evaluation and fairer remuneration of work in female-dominated sectors Adopted 458 for, 72 against, 98 abstainedPosition: For Majority line: For
11 Mar 2026European Semester for economic policy coordination 2026 Adopted 392 for, 219 against, 18 abstainedPosition: For Majority line: For
11 Mar 2026European Semester for economic policy coordination: employment and social priorities for 2026 Adopted 404 for, 208 against, 20 abstainedPosition: For Majority line: For
11 Mar 2026EU enlargement strategy Adopted 385 for, 147 against, 98 abstainedPosition: For Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 2 of 34 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within Greens

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Mélissa CAMARA GreensFrance98 % of 4 768 shared94 %
David CORMAND GreensFrance97 % of 5 358 shared94 %
Mounir SATOURI GreensFrance97 % of 4 894 shared94 %
Majdouline SBAI GreensFrance97 % of 2 712 shared94 %
Tilly METZ GreensLuxembourg96 % of 5 327 shared94 %
Saskia BRICMONT GreensBelgium96 % of 5 221 shared94 %
Nicolae ȘTEFĂNUȚĂ GreensRomania94 % of 3 499 shared94 %
Gordan BOSANAC GreensCroatia93 % of 5 440 shared94 %
Sara MATTHIEU GreensBelgium93 % of 4 812 shared94 %
Benedetta SCUDERI GreensItaly92 % of 5 281 shared94 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Merja KYLLÖNEN The LeftFinland88 % of 5 175 shared77 %
Li ANDERSSON The LeftFinland88 % of 5 131 shared77 %
Jussi SARAMO The LeftFinland88 % of 5 500 shared77 %
Estelle CEULEMANS S&DBelgium87 % of 5 205 shared83 %
Younous OMARJEE The LeftFrance87 % of 3 990 shared77 %
Aurore LALUCQ S&DFrance87 % of 4 350 shared83 %
Raphaël GLUCKSMANN S&DFrance86 % of 4 978 shared83 %
Emma RAFOWICZ S&DFrance86 % of 4 012 shared83 %
Thomas PELLERIN-CARLIN S&DFrance85 % of 5 369 shared83 %
Pierre JOUVET S&DFrance85 % of 4 774 shared83 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on Economic and Monetary AffairsECON CommitteeMember19 Jul 2024now
Committee on the Environment, Climate and Food SafetyENVI CommitteeSubstitute20 Jan 2025now
Committee on Industry, Research and EnergyITRE CommitteeSubstitute19 Jul 2024now
Committee on Public HealthSANT CommitteeSubstitute23 Jan 2025now
Subcommittee on Tax MattersFISC SubcommitteeSubstitute19 Jul 2024now
Special Committee on the Housing Crisis in the European UnionHOUS Special committeeSubstitute23 Jan 2025now
Delegation for relations with the Federative Republic of BrazilD-BR DelegationSubstitute6 Mar 2025now
Delegation to the Euro-Latin American Parliamentary AssemblyDLAT Parliamentary assemblySubstitute19 Sept 2024now
Intergroup on Anti-Racism and DiversityIG10-02 Intergroup / working groupMember14 Feb 2025now
Intergroup on Children’s RightsIG10-06 Intergroup / working groupMember19 Feb 2025now

Show all 20 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act)Shadow rapporteurSANT15 Jul 2026
Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act)Shadow rapporteurITRE30 Mar 2026
Guidelines for trans-European energy infrastructure, amending Regulations (EU) 2019/942, (EU) 2019/943 and (EU) 2024/1789 and repealing Regulation (EU) 2022/869Shadow rapporteur for an opinionENVI25 Mar 2026
Amending Decision (EU) 2015/1814 as regards the market stability reserve for the buildings, road transport and additional sectorShadow rapporteurENVI26 Feb 2026
Amending Decision (EU) 2015/1814 as regards the market stability reserve for the buildings, road transport and additional sectorShadow rapporteurENVI20 Feb 2026
Empowering France to accede to the Inter-American Convention for the Protection and Conservation of Sea TurtlesShadow rapporteurENVI2 Feb 2026
Financial literacy and the rise of finfluencers in the context of the savings and investments unionShadow rapporteurECON15 Dec 2025
Amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradersShadow rapporteurENVI1 Dec 2025
Amending Regulation (EU) No 575/2013 on prudential requirements for credit institutions as regards requirements for securitisation exposuresShadow rapporteurECON10 Nov 2025
Amending Regulation (EU) 2017/2402 laying down a general framework for securitisation and creating a specific framework for simple, transparent and standardised securitisationShadow rapporteurECON3 Oct 2025

Show all 16 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

65 contributions recorded; 20 on behalf of their group; 101 minutes of speaking time.

Show all 40 recent contributions

Questions and motions, 96

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
13 Sept 2026Repeated ban on Oradea Pride and compliance with fundamental rights in the use of EU funds E-10-2026-003648Written questionwith 17 co-authorsNot yet answered
10 Sept 2026EU exports of banned pesticides E-10-2026-003605Written questionwith 35 co-authorsNot yet answered
8 Sept 2026Chatbots directing women with unwanted pregnancies to anti-abortion websites E-10-2026-003539Written questionwith 67 co-authorsNot yet answered
7 Sept 2026Climate change, public health and the world of work: for a directive on maximum working temperatures O-10-2026-000035Oral questionwith 35 co-authorsNot yet answered
8 Jul 2026European funds allocated to fighting period poverty E-10-2026-002822Written questionwith 36 co-authorsNot yet answered
7 Jul 2026Transparency regarding EU-funded infrastructure destroyed in Gaza E-10-2026-002805Written questionwith 39 co-authors4 Sept 2026
1 Jul 2026Operation ENTOS in Greece E-10-2026-002721Written question14 Aug 2026
1 Jul 2026PROPOSAL FOR A DECISION requesting the Authority for European Political Parties and European Political Foundations to verify whether Europe of Sovereign Nations Party complies with the conditions laid down in Article 3(1), points (d) and (e), of Regulation (EU, Euratom) 2025/2445 B-10-2026-0338Motion for a resolutionwith 246 co-authors—
29 Jun 2026Compliance with Chapter 27 benchmarks and the EU environmental acquis in relation to developments in the Vjosa-Narta Protected Area in Albania P-10-2026-002691Priority written questionwith 12 co-authors22 Sept 2026
17 Jun 2026Request that the Commission publish evidence pertaining to the non-activation of the Blocking Statute E-10-2026-002520Written questionwith 31 co-authorsNot yet answered

Show all 96 questions and motions

Amendments tabled in committee, 35

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790953 CJ5314
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938 CJ5321
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939 CJ5311
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790005 CJ5312
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790932 CJ5322
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790933 CJ5320
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934 CJ5320
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790935 CJ5322
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936 CJ5322
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937 CJ5313

Show all 35 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political groups this term

National delegation

  • Delegation France National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Marie TOUSSAINT”. Member record. memberId 97236. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/97236?page=4&period=2026 (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/97236. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/97236?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-97236,
  author = {{EU Parl Watch Research}},
  title = {{Marie TOUSSAINT}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/97236?page=4&period=2026}},
  url = {https://news.eu-parl.st-solutions.dev/members/97236?page=4&period=2026},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 97236. Official source: https://www.europarl.europa.eu/meps/en/97236. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}